Publications by authors named "J N Maslow"

Article Synopsis
  • * Conducted over three decades at a trauma center, this retrospective case series analyzed 88 cases and identified complications like stiffness, partial flap loss, and infection, with patients averaging four surgeries post-injury.
  • * Findings suggest that patients should prepare for multiple surgeries, especially in cases of high-energy injuries, which are associated with increased surgical intervention.
View Article and Find Full Text PDF

Electrospray deposition (ESD) is a promising technique for depositing micro-/nano-scale droplets and particles with high quality and repeatability. It is particularly attractive for surface coating of costly and delicate biomaterials and bioactive compounds. While high efficiency of ESD has only been successfully demonstrated for spraying surfaces larger than the spray plume, this work extends its utility to smaller surfaces.

View Article and Find Full Text PDF

The current clinical assessment of fracture risk lacks information about the inherent quality of a person's bone tissue. Working toward an imaging-based approach to quantify both a bone tissue quality marker (tissue hydration as water bound to the matrix) and a bone microstructure marker (porosity as water in pores), we hypothesized that the concentrations of bound water (C) are lower and concentrations of pore water (C) are higher in patients with osteoporosis (OP) than in age- and sex-matched adults without the disease. Using recent developments in ultrashort echo time (UTE) magnetic resonance imaging (MRI), maps of C and C were acquired from the uninjured distal third radius (Study 1) of 20 patients who experienced a fragility fracture of the distal radius (Fx) and 20 healthy controls (Non-Fx) and from the tibia mid-diaphysis (Study 2) of 30 women with clinical OP (low T-scores) and 15 women without OP (normal T-scores).

View Article and Find Full Text PDF

We highlight the significant progress in developing DNA vaccines during the SARS-CoV-2 pandemic. Specifically, we provide a comprehensive review of the DNA vaccines that have progressed to Phase 2 testing or beyond, including those that have received authorization for use. DNA vaccines have significant advantages with regard to the rapidity of production, thermostability, safety profile, and cellular immune responses.

View Article and Find Full Text PDF
Article Synopsis
  • Heterologous boost regimens involving an mRNA vaccine after a DNA vaccine are gaining interest for enhancing immunity against SARS-CoV-2.
  • In a clinical trial with 32 participants, those who received an mRNA vaccine 6 to 8 months after the GLS-5310 DNA vaccine reported no adverse events, indicating a good safety profile.
  • The study found significant improvements in immune responses, with increased antibody and T-cell levels, marking it as the first report on immune responses from this specific vaccination strategy.
View Article and Find Full Text PDF